Bookmark and Share
m1-family aminopeptidase [Plasmodium falcipar.. [gi:23615263] - Target BioActivity Data
Also known as: m1-family aminopeptidase [Plasmodium falciparum 3D7].
BioActivity Outcomes:
Active(60)
 
 
Inactive(102)
 
 
Inconclusive(5)
 
 
BioAssay Types:
Confirmatory(167)
 
 
 
 
BioActivity Types:
IC50(167)
 
 
 
 
Substance Types:
Chemical(167)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 7    Data Row: 167   Total Pages: 4   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID125311595]
[CID53384804]
Average PFM1AAP IC50 1.41Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
2
[SID99431869]
[CID3245751]
Average PFM1AAP IC50 1.54QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) (2) [AID602213, Type: confirmatory]
View
3
[SID125321394]
[CID16002643]
Average PFM1AAP IC50 2.26QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) (2) [AID602213, Type: confirmatory]
View
4
[SID125311594]
[CID53315819]
Average PFM1AAP IC50 2.57Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
5
[SID125311588]
[CID14545018]
Average PFM1AAP IC50 2.89Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
6
[SID125311597]
[CID12814959]
Average PFM1AAP IC50 4.58Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
7
[SID125321393]
[CID22430551]
Average PFM1AAP IC50 5.05QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) (2) [AID602213, Type: confirmatory]
View
8
[SID125311591]
[CID53315818]
Average PFM1AAP IC50 5.45Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
9
[SID125311598]
[CID23380591]
Average PFM1AAP IC50 5.77Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
10
[SID125311590]
[CID4589721]
Average PFM1AAP IC50 7Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
11
[SID110722946]
[CID50904127]
Average PFM1AAP IC50 11.37QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) [AID588686, Type: confirmatory]
View
12
[SID125311596]
[CID142752]
Average PFM1AAP IC50 13.34Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
13
[SID93577810]
[CID2466]
Average PFM1AAP IC50 13.97Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
14
[SID99431820]
[CID26912015]
Average PFM1AAP IC50 14.56QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) (2) [AID602213, Type: confirmatory]
View
15
[SID131485162]
[CID25922]
Average PFM1AAP IC50 16.66Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory]
View
16
[SID124767890]
[CID53308676]
Average PFM1AAP IC50 19.65Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
17
[SID104233703]
[CID49859553]
Average PFM1AAP IC50 19.94Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
18
[SID131485166]
[CID54758532]
Average PFM1AAP IC50 20.22Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory]
View
19
[SID125311608]
[CID53315822]
Average PFM1AAP IC50 23.18Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View
20
[SID103911645]
[CID27888076]
Average PFM1AAP IC50 23.8QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) [AID588686, Type: confirmatory]
View
21
[SID99343884]
[CID751856]
Average PFM1AAP IC50 25.9Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602219, Type: confirmatory]
View
22
[SID131485168]
[CID54758533]
Average PFM1AAP IC50 25.99Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory]
View
23
[SID131485172]
[CID53315831]
Average PFM1AAP IC50 28.21Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory]
View
24
[SID126490285]
[CID53464134]
Average PFM1AAP IC50 29.83Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602219, Type: confirmatory]
View
25
[SID124767874]
[CID53308675]
Average PFM1AAP IC50 29.93Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
26
[SID104233677]
[CID24689999]
Average PFM1AAP IC50 33.67Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588698, Type: confirmatory]
View
27
[SID124767875]
[CID53308684]
Average PFM1AAP IC50 34.61Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
28
[SID124767868]
[CID53308667]
Average PFM1AAP IC50 34.96Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
29
[SID124767873]
[CID53308680]
Average PFM1AAP IC50 35.65Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
30
[SID104233699]
[CID17467002]
Average PFM1AAP IC50 37.12Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
31
[SID104233704]
[CID47034404]
Average PFM1AAP IC50 37.69Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
32
[SID104233692]
[CID6098495]
Average PFM1AAP IC50 39.93Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
33
[SID104233697]
[CID17543044]
Average PFM1AAP IC50 40.04Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
34
[SID104233706]
[CID2412200]
Average PFM1AAP IC50 40.04Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
35
[SID104233688]
[CID5077057]
Average PFM1AAP IC50 40.34Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
36
[SID104233686]
[CID2815223]
Average PFM1AAP IC50 41.21Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
37
[SID104233690]
[CID3140538]
Average PFM1AAP IC50 42.17Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
38
[SID124767897]
[CID53308664]
Average PFM1AAP IC50 45.17Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
39
[SID124767892]
[CID13162550]
Average PFM1AAP IC50 46.42Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602219, Type: confirmatory]
View
40
[SID104233684]
[CID5281416]
Average PFM1AAP IC50 48.2Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
41
[SID110722942]
[CID50904123]
Average PFM1AAP IC50 49.91QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1 Alanyl Aminopeptidase (PFM1AAP) [AID588686, Type: confirmatory]
View
42
[SID104233685]
[CID49859557]
Average PFM1AAP IC50 54.29Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
43
[SID124767902]
[CID53308670]
Average PFM1AAP IC50 55.13Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
44
[SID99343875]
[CID17462570]
Average PFM1AAP IC50 62.98Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602219, Type: confirmatory]
View
45
[SID99343867]
[CID8895585]
Average PFM1AAP IC50 70.05Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602219, Type: confirmatory]
View
46
[SID104233709]
[CID3697750]
Average PFM1AAP IC50 76.7Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
47
[SID124767872]
[CID53308668]
Average PFM1AAP IC50 77.04Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
48
[SID104233678]
[CID289794]
Average PFM1AAP IC50 79.39Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588698, Type: confirmatory]
View
49
[SID104233707]
[CID5582251]
Average PFM1AAP IC50 90.52Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]
View
50
[SID125311593]
[CID53384800]
Average PFM1AAP IC50 95.76Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (2) [AID602223, Type: confirmatory]
View